Original article by Stephen Cauchi
The Australian Financial Review – Page: 16 : 20-Mar-15

Australian-listed Sigma Pharmaceuticals has posted an after-tax net profit of $A52.7m for the year to 31 January 2015, compared with $A53.5m previously. EBIT rose by 11 per cent to $A78m and revenue increased by 5.7 per cent to $A3.1bn. Sigma will pay a final dividend of $A0.02 per share, while investors will also receive a special dividend of $A0.01 per share

CORPORATES
SIGMA PHARMACEUTICALS LIMITED – ASX SIP, STANDARD AND POOR’S ASX 200 INDEX